- Application under evaluation
- CHMP opinion
- European Commission decision
Overview
The marketing authorisation for Intrinsa has been withdrawn at the request of the marketing-authorisation holder.
Intrinsa : EPAR - Summary for the public
English (EN) (282.58 KB - PDF)
български (BG) (291.39 KB - PDF)
español (ES) (224.65 KB - PDF)
čeština (CS) (266.63 KB - PDF)
dansk (DA) (243.36 KB - PDF)
Deutsch (DE) (225.77 KB - PDF)
eesti keel (ET) (223.17 KB - PDF)
ελληνικά (EL) (298.11 KB - PDF)
français (FR) (225.04 KB - PDF)
italiano (IT) (225.26 KB - PDF)
latviešu valoda (LV) (270.17 KB - PDF)
lietuvių kalba (LT) (250.28 KB - PDF)
magyar (HU) (262.07 KB - PDF)
Malti (MT) (265.74 KB - PDF)
Nederlands (NL) (223.92 KB - PDF)
polski (PL) (263.45 KB - PDF)
português (PT) (224.53 KB - PDF)
română (RO) (249.31 KB - PDF)
slovenčina (SK) (265.91 KB - PDF)
slovenščina (SL) (261.6 KB - PDF)
Suomi (FI) (223.94 KB - PDF)
svenska (SV) (239.94 KB - PDF)
Product information
Intrinsa : EPAR - Product Information
English (EN) (604.23 KB - PDF)
български (BG) (776.04 KB - PDF)
español (ES) (375.27 KB - PDF)
čeština (CS) (620.46 KB - PDF)
dansk (DA) (521.26 KB - PDF)
Deutsch (DE) (394.85 KB - PDF)
eesti keel (ET) (374.96 KB - PDF)
ελληνικά (EL) (830.64 KB - PDF)
français (FR) (330.76 KB - PDF)
íslenska (IS) (374.24 KB - PDF)
italiano (IT) (324.41 KB - PDF)
latviešu valoda (LV) (703.49 KB - PDF)
lietuvių kalba (LT) (464.98 KB - PDF)
magyar (HU) (613.6 KB - PDF)
Malti (MT) (665.61 KB - PDF)
Nederlands (NL) (381.49 KB - PDF)
norsk (NO) (371.26 KB - PDF)
polski (PL) (585.39 KB - PDF)
português (PT) (324.27 KB - PDF)
română (RO) (477.78 KB - PDF)
slovenčina (SK) (639.84 KB - PDF)
slovenščina (SL) (604.52 KB - PDF)
Suomi (FI) (378.55 KB - PDF)
svenska (SV) (377.35 KB - PDF)
This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
Intrinsa : EPAR - All Authorised presentations
English (EN) (234.95 KB - PDF)
български (BG) (172.54 KB - PDF)
español (ES) (115.87 KB - PDF)
čeština (CS) (156.31 KB - PDF)
dansk (DA) (126.77 KB - PDF)
Deutsch (DE) (115.61 KB - PDF)
eesti keel (ET) (115.83 KB - PDF)
ελληνικά (EL) (126.29 KB - PDF)
français (FR) (115.48 KB - PDF)
íslenska (IS) (115.41 KB - PDF)
italiano (IT) (115.35 KB - PDF)
latviešu valoda (LV) (162.57 KB - PDF)
lietuvių kalba (LT) (156.14 KB - PDF)
magyar (HU) (136.21 KB - PDF)
Malti (MT) (168.15 KB - PDF)
Nederlands (NL) (115.96 KB - PDF)
norsk (NO) (116.07 KB - PDF)
polski (PL) (139.9 KB - PDF)
português (PT) (115.29 KB - PDF)
română (RO) (154.68 KB - PDF)
slovenčina (SK) (153.89 KB - PDF)
slovenščina (SL) (139.86 KB - PDF)
Suomi (FI) (115.27 KB - PDF)
svenska (SV) (115.55 KB - PDF)
Product details
- Name of medicine
- Intrinsa
- Active substance
- Testosterone
- International non-proprietary name (INN) or common name
- testosterone
- Therapeutic area (MeSH)
- Sexual Dysfunctions, Psychological
- Anatomical therapeutic chemical (ATC) code
- G03BA03
Pharmacotherapeutic group
Sex hormones and modulators of the genital systemTherapeutic indication
Intrinsa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.
Authorisation details
- EMA product number
- EMEA/H/C/000634
- Marketing authorisation holder
- Warner Chilcott UK Ltd.
Old Belfast Road
Milbrook
Larne
County Antrim
BT40 2SH
United Kingdom - Marketing authorisation issued
- 28/07/2006
- Revision
- 6
Assessment history
Intrinsa : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (181.31 KB - PDF)
News on Intrinsa
More information on Intrinsa
Public statement on Intrinsa: Withdrawal of the marketing authorisation in the European Union
English (EN) (61.53 KB - PDF)